Abstract
Polycystic ovary syndrome (PCOS) is a complex and heterogeneous disease that involves menstrual dysfunction and reproductive difficulty as well as metabolic problems. From a genetic point of view, it is a complex disease that is subject to environmental influences, mainly dietary, which makes it similar to other metabolic processes, such as diabetes and obesity. So, the interest of the diagnosis of the PCOS is, not only to improve fertility but to prevent possible future medical complications like the diabetes mellitus and the obesity.
Due to the classical definition of PCOS as functional hyperandrogenism, the race to discover genetic alterations that could lead to the development of PCOS started with the androgen metabolism genes. However, the list of candidates was later expanded to other genes outside this hormonal pathway, and it now includes genes involved in carbohydrate and lipid metabolism as well as those involved in inflammatory processes.
Synopsis: The list of genes candidates involved in PCOS is related to diabetes and inflammatory processes.
Keywords: Polymorphism, Polycystic ovary syndrome, Insulin resistance, Diabetes Mellitus, obesity, hyperandrogenism, trauma, haemorrhage, Hyperinsulinism, GWAs
Current Diabetes Reviews
Title: Common Genetic Aspects Between Polycystic Ovary Syndrome and Diabetes Mellitus
Volume: 7 Issue: 6
Author(s): Nicolas Mendoza
Affiliation:
Keywords: Polymorphism, Polycystic ovary syndrome, Insulin resistance, Diabetes Mellitus, obesity, hyperandrogenism, trauma, haemorrhage, Hyperinsulinism, GWAs
Abstract: Polycystic ovary syndrome (PCOS) is a complex and heterogeneous disease that involves menstrual dysfunction and reproductive difficulty as well as metabolic problems. From a genetic point of view, it is a complex disease that is subject to environmental influences, mainly dietary, which makes it similar to other metabolic processes, such as diabetes and obesity. So, the interest of the diagnosis of the PCOS is, not only to improve fertility but to prevent possible future medical complications like the diabetes mellitus and the obesity.
Due to the classical definition of PCOS as functional hyperandrogenism, the race to discover genetic alterations that could lead to the development of PCOS started with the androgen metabolism genes. However, the list of candidates was later expanded to other genes outside this hormonal pathway, and it now includes genes involved in carbohydrate and lipid metabolism as well as those involved in inflammatory processes.
Synopsis: The list of genes candidates involved in PCOS is related to diabetes and inflammatory processes.
Export Options
About this article
Cite this article as:
Mendoza Nicolas, Common Genetic Aspects Between Polycystic Ovary Syndrome and Diabetes Mellitus, Current Diabetes Reviews 2011; 7 (6) . https://dx.doi.org/10.2174/157339911797579142
DOI https://dx.doi.org/10.2174/157339911797579142 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
Call for Papers in Thematic Issues
Advancing Diabetic Wound Healing: Mechanisms and Interventions
In recent years, diabetic wounds have become a global health concern with the increase in the incidence of diabetes. Diabetic wounds are a kind of chronic and refractory ulcer. It is generally due to the microcirculatory disturbances and the reduced levels of endogenous growth factors. Delayed cutaneous wound healing is ...read more
Oxidative and inflammatory responses in the development of secondary diabetic complications
Diabetes, along with its associated secondary complications, represents a significant global health challenge, contributing significantly to morbidity and mortality. Unhealthy lifestyle habits, reduced physical activity, environmental pollutants, and stress are pivotal factors in the onset of diabetes, particularly type-2 diabetes. Poorly managed hyperglycemia can lead to various complications, including neuropathy, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Mutations of mtDNA in some Vascular and Metabolic Diseases
Current Pharmaceutical Design Endothelial Function in Renal Transplant Recipients is Associated with Circulating Nitric Oxide, ACE Inhibitor Use and Time After Transplantation
Vascular Disease Prevention (Discontinued) Gene Expression Profiling in Rodent Models for Schizophrenia
Current Neuropharmacology Management of Hypertension-Journey from Single Drug Therapy to Multitargeted Ligand Therapy: A Clinical Overview
Current Clinical Pharmacology Predictive Factors of follow-up Non-attendance and Mortality Among Adults with Type 2 Diabetes Mellitus- an Analysis of the Malaysian Diabetes Registry 2009
Current Diabetes Reviews HIV Infection, Antiretroviral Therapy Initiation and Longitudinal Changes in Biomarkers of Organ Function
Current HIV Research Contribution of Inflammation to Fat Redistribution and Metabolic Disturbances in HIV-1 Infected Patients
Current Pharmaceutical Design Mind-Body Therapies and Osteoarthritis of the Knee
Current Rheumatology Reviews Defective Autophagy in Fibroblasts May Contribute to Fibrogenesis in Autoimmune Processes
Current Pharmaceutical Design Microencapsulation: Techniques, Food Applications and Pest Control
Recent Patents on Engineering Structural Insight into PPARγ Ligands Binding
Current Medicinal Chemistry Assay of the Glucose Consumption Rate in Liver with a Novel Colorimetric Method
Current Pharmaceutical Analysis Effect of Dapagliflozin on Intestinal Flora in MafA-deficient Mice
Current Pharmaceutical Design Eye Disorders in Diabetes: Potential Drug Targets
Infectious Disorders - Drug Targets The Role of HLA Promoters in Autoimmunity
Current Pharmaceutical Design Variability in the Response to Non-pharmacological Treatments in Patients with Cardiovascular Diseases
Current Pharmacogenomics and Personalized Medicine SHIP2: An Emerging Target for the Treatment of Type 2 Diabetes Mellitus
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Arterial Stiffness: A Novel Cardiovascular Risk Factor in Kidney Disease Patients
Current Vascular Pharmacology Effects of Insulin on the Vasculature
Current Vascular Pharmacology Angiogenesis, Neurogenesis and Neuroplasticity in Ischemic Stroke
Current Cardiology Reviews